XML 82 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Number of Ordinary Shares
Number of Founder Share
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
 [1]
Accumulated Deficit
Total
Balance at Dec. 31, 2021     $ 1,148,461 $ 594 $ (445,660) $ 703,395
Balance, shares at Dec. 31, 2021 44,924,039 1        
Exercise of options     6,133 0 0 6,133
Exercise of options (in shares) 2,693,614 0        
Issuance of ordinary shares upon the vesting and settlement of restricted stock units     0 0 0 0
Issuance of ordinary shares upon the vesting and settlement of restricted stock units (in shares) 81,976 0        
Issuance of ordinary shares under employee share purchase plan     3,681 0 0 3,681
Issuance of ordinary shares under employee share purchase plan (in shares) 38,239 0        
Share-based compensation $ 0   107,202 0 0 107,202
Other comprehensive loss 0   0 (3,804) 0 (3,804)
Net income (loss) 0   0 0 (136,867) (136,867)
Balance at Dec. 31, 2022 $ 47,737,868   1,265,477 (3,210) (582,527) 679,740
Balance, shares at Dec. 31, 2022   1        
Exercise of options     11,666 0 0 11,666
Exercise of options (in shares) 767,148 0        
Issuance of ordinary shares upon the vesting and settlement of restricted stock units     0 0 0 0
Issuance of ordinary shares upon the vesting and settlement of restricted stock units (in shares) 338,034 0        
Issuance of ordinary shares under employee share purchase plan     8,782 0 0 8,782
Issuance of ordinary shares under employee share purchase plan (in shares) 80,853 0        
Share-based compensation $ 0   102,183 0 0 102,183
Other comprehensive loss 0   0 13,014 0 13,014
Net income (loss) 0   0 0 (1,877) (1,877)
Balance at Dec. 31, 2023 $ 48,923,903   1,388,108 9,804 (584,404) 813,508
Balance, shares at Dec. 31, 2023 48,923,903 1        
Exercise of options     29,421 0 0 $ 29,421
Exercise of options (in shares) 1,220,551 0       1,220,551
Issuance of ordinary shares upon the vesting and settlement of restricted stock units     0 0 0 $ 0
Issuance of ordinary shares upon the vesting and settlement of restricted stock units (in shares) 483,508 0        
Issuance of ordinary shares under employee share purchase plan     13,284 0 0 13,284
Issuance of ordinary shares under employee share purchase plan (in shares) 77,375 0        
Share-based compensation $ 0   130,353 0 0 $ 130,353
Charitable share contribution to Foundation (in shares) 68,000 0       68,000
Charitable share contribution to Foundation     17,908 0 0 $ 17,908
Other comprehensive loss $ 0   0 (6,615) 0 (6,615)
Net income (loss) 0   0 0 32,372 32,372
Balance at Dec. 31, 2024 $ 50,773,337   $ 1,579,074 $ 3,189 $ (552,032) $ 1,030,231
Balance, shares at Dec. 31, 2024   1        
[1] As of December 31, 2024 and 2023, accumulated other comprehensive income (loss) is comprised of unrealized gains on derivatives of $2,982 and 9,804, respectively, and unrealized gains on marketable securities of $207 and $0, respectively.